PubRank
Search
About
Zhi-Zhou Shi
Author PubWeight™ 9.61
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.
Int J Cancer
2009
1.23
2
Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma.
Genes Chromosomes Cancer
2008
1.20
3
Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Mol Cancer Res
2011
0.93
4
PLK1 Is transcriptionally activated by NF-κB during cell detachment and enhances anoikis resistance through inhibiting β-catenin degradation in esophageal squamous cell carcinoma.
Clin Cancer Res
2011
0.90
5
Characterization of gene rearrangements resulted from genomic structural aberrations in human esophageal squamous cell carcinoma KYSE150 cells.
Gene
2012
0.88
6
Analysis of genomic aberrations associated with the clinicopathological parameters of rectal cancer by array‑based comparative genomic hybridization.
Oncol Rep
2013
0.78
7
[Expression of cell cycle related proteins cyclin D1, p53 and p21WAF1/Cip1 in esophageal squamous cell carcinoma].
Yi Chuan
2010
0.78
8
Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors.
BMC Cancer
2012
0.77
9
Genomic changes in rectal adenocarcinoma associated with liver metastasis.
Cancer Biomark
2013
0.76
10
Inhibition of atypical protein kinase Cι induces apoptosis through autophagic degradation of β-catenin in esophageal cancer cells.
Mol Carcinog
2013
0.76
11
PKCι counteracts oxidative stress by regulating Hsc70 in an esophageal cancer cell line.
Cell Stress Chaperones
2012
0.75
12
MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets.
Cancer Biomark
2017
0.75
13
MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Cancer Biomark
2017
0.75